Observatoire des droits humains (anglais seulement)

Could a new type of weight-loss pill shake up the market? Here’s what to know about orforglipron

(Version anglaise seulement)

par Martin Whyte, Associate Professor of Metabolic Medicine, University of Surrey

A new type of daily pill has proven more effective for weight loss and blood sugar control than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in the rapidly expanding oral weight-loss drug market.

The advent of the injectable weight-loss drug semaglutide (known better by its brand names Wegovy and Ozempic) marked a distinct shift in the weight-loss drugs market when it became available just a few years ago.

Semaglutide is a class of glucagon-like peptide-1 (GLP-1) medication. These drugs mimic…

Lire l'article complet